Premarket Mover: Aclaris Therapeutics Inc (ACRS) Up 7.37%

Aclaris Therapeutics Inc (ACRS) is up Monday morning, with the stock increasing 7.37% in pre-market trading to 1.02. ACRS's short-term technical score of 1 indicates that the stock has traded less bullishly over the last month than 99% of stocks on the market. In the Diagnostics & Research industry, which ranks 118 out of 146 industries, the stock ranks higher than 2% of stocks. Aclaris Therapeutics Inc has fallen 82.01% over the past month, closing at $4.98 on October 23. During this period of time, the stock fell as low as $0.64 and as high as $5.71. ACRS has an average analyst recommendation of Buy. The company has an average price target of $8.38.

ACRS has an Overall Score of 32. Find out what this means to you and get the rest of the rankings on ACRS!

See Full ACRS Report

Aclaris Therapeutics Inc has a Long-Term Technical rank of 0. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 100% of the market scoring higher. In the Diagnostics & Research industry which is number 125 by this metric, ACRS ranks better than 125% of stocks.

Important Dates for Investors in ACRS:

-Aclaris Therapeutics Inc is set to release earnings on 2024-02-04. Over the last 12 months, the company has reported EPS of $-1.55. -We do not have a set dividend date for Aclaris Therapeutics Inc at this time. Click Here To Get The Full Report on Aclaris Therapeutics Inc (ACRS)